Role of BDNF signaling in the neuroprotective and memory-enhancing effects of flavonoids in Alzheimer's Disease
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
INTRODUCTION: Foods rich in flavonoids are associated with a reduced risk of various chronic diseases, including Alzheimer's disease (AD). In fact, growing evidence suggests that consuming flavonoid-rich foods can beneficially affect normal cognitive function. Animal models have shown that many flavonoids prevent the development of AD-like pathology and improve cognitive deficits.
RESULT: Flavonoid-rich foods, such as green tea and blueberries, must exert their effect through the direct interaction of absorbed flavonoids and their metabolites with cellular and molecular targets.
CONCLUSION: Based on the most recent scientific literature, this review article critically examines the therapeutic role of dietary flavonoids in ameliorating and preventing the progression of AD and focuses on the role of the BDNF signaling pathway in the neuroprotective effects of flavonoids.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
|---|---|
| Enthalten in: |
CNS & neurological disorders drug targets - (2023) vom: 12. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Amidfar, Meysam [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Alzheimer’s disease |
|---|
| Anmerkungen: |
Date Revised 13.09.2023 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2174/1871527323666230912090856 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361994915 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361994915 | ||
| 003 | DE-627 | ||
| 005 | 20231226090320.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/1871527323666230912090856 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1206.xml |
| 035 | |a (DE-627)NLM361994915 | ||
| 035 | |a (NLM)37702162 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Amidfar, Meysam |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Role of BDNF signaling in the neuroprotective and memory-enhancing effects of flavonoids in Alzheimer's Disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 13.09.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a INTRODUCTION: Foods rich in flavonoids are associated with a reduced risk of various chronic diseases, including Alzheimer's disease (AD). In fact, growing evidence suggests that consuming flavonoid-rich foods can beneficially affect normal cognitive function. Animal models have shown that many flavonoids prevent the development of AD-like pathology and improve cognitive deficits | ||
| 520 | |a RESULT: Flavonoid-rich foods, such as green tea and blueberries, must exert their effect through the direct interaction of absorbed flavonoids and their metabolites with cellular and molecular targets | ||
| 520 | |a CONCLUSION: Based on the most recent scientific literature, this review article critically examines the therapeutic role of dietary flavonoids in ameliorating and preventing the progression of AD and focuses on the role of the BDNF signaling pathway in the neuroprotective effects of flavonoids | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Alzheimer’s disease | |
| 650 | 4 | |a BDNF | |
| 650 | 4 | |a flavonoids | |
| 650 | 4 | |a memory | |
| 650 | 4 | |a neuroprotection | |
| 700 | 1 | |a Garcez, Michelle Lima |e verfasserin |4 aut | |
| 700 | 1 | |a Askari, Gholamreza |e verfasserin |4 aut | |
| 700 | 1 | |a Bagherniya, Mohammad |e verfasserin |4 aut | |
| 700 | 1 | |a Khorvash, Fariborz |e verfasserin |4 aut | |
| 700 | 1 | |a Hamedani, Sahar Golpour |e verfasserin |4 aut | |
| 700 | 1 | |a de Oliveira, Jade |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t CNS & neurological disorders drug targets |d 2006 |g (2023) vom: 12. Sept. |w (DE-627)NLM161975518 |x 1996-3181 |7 nnns |
| 773 | 1 | 8 | |g year:2023 |g day:12 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/1871527323666230912090856 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2023 |b 12 |c 09 | ||